tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

AU:NOX Stock Latest News

Noxopharm Limited Announces 2025 AGM Details and Key Resolutions
Company AnnouncementsNoxopharm Limited Announces 2025 AGM Details and Key Resolutions
8d ago
NOX
Noxopharm Advances Clinical Trials, Boosts Stakeholder Interest
PremiumCompany Announcements
Noxopharm Advances Clinical Trials, Boosts Stakeholder Interest
8d ago
NOX
Noxopharm Releases FY2025 Governance Documents
PremiumCompany Announcements
Noxopharm Releases FY2025 Governance Documents
8d ago
NOX
Noxopharm Advances Drug Development with New Trials and Strategic Partnerships
PremiumCompany Announcements
Noxopharm Advances Drug Development with New Trials and Strategic Partnerships
22d ago
NOX
Noxopharm Secures Financial Extensions and Additional Funding
PremiumCompany Announcements
Noxopharm Secures Financial Extensions and Additional Funding
28d ago
NOX
Noxopharm Achieves Milestone in Autoimmune Drug Development with HERACLES Trial Completion
PremiumCompany AnnouncementsNoxopharm Achieves Milestone in Autoimmune Drug Development with HERACLES Trial Completion
1M ago
NOX
Noxopharm Reports Increased Annual Loss Amidst Ongoing Challenges
Premium
Company Announcements
Noxopharm Reports Increased Annual Loss Amidst Ongoing Challenges
2M ago
NOX
Noxopharm Advances HERACLES Trial for Autoimmune Drug SOF-SKN™
Premium
Company Announcements
Noxopharm Advances HERACLES Trial for Autoimmune Drug SOF-SKN™
2M ago
NOX
Noxopharm Advances HERACLES Trial for Autoimmune Drug SOF-SKN™
PremiumCompany Announcements
Noxopharm Advances HERACLES Trial for Autoimmune Drug SOF-SKN™
2M ago
NOX
Noxopharm Advances Clinical Trials and Expands Collaborations
PremiumCompany Announcements
Noxopharm Advances Clinical Trials and Expands Collaborations
3M ago
NOX
Noxopharm Initiates First SOF-SKN™ Dose in HERACLES Trial
PremiumCompany Announcements
Noxopharm Initiates First SOF-SKN™ Dose in HERACLES Trial
3M ago
NOX
Noxopharm Advances HERACLES Clinical Trial for Autoimmune Drug
PremiumCompany Announcements
Noxopharm Advances HERACLES Clinical Trial for Autoimmune Drug
4M ago
NOX
Noxopharm’s Sofra Platform Shows Promising Results in BioRay Collaboration
PremiumCompany AnnouncementsNoxopharm’s Sofra Platform Shows Promising Results in BioRay Collaboration
4M ago
NOX
Noxopharm Secures Ethics Approval for Pioneering HERACLES Clinical Trial
Premium
Company Announcements
Noxopharm Secures Ethics Approval for Pioneering HERACLES Clinical Trial
5M ago
NOX
Noxopharm Reduces Stake in Nyrada Inc.
Premium
Company Announcements
Noxopharm Reduces Stake in Nyrada Inc.
5M ago
NOX
Noxopharm Sells Entire Stake in Nyrada Inc., Restructuring Corporate Holdings
PremiumCompany Announcements
Noxopharm Sells Entire Stake in Nyrada Inc., Restructuring Corporate Holdings
5M ago
NOX
Noxopharm Secures $2.5 Million for Clinical Trials and R&D
PremiumCompany Announcements
Noxopharm Secures $2.5 Million for Clinical Trials and R&D
5M ago
NOX
Noxopharm Unveils Promising SOF-SKN Data at Rheumatology Conference
PremiumCompany Announcements
Noxopharm Unveils Promising SOF-SKN Data at Rheumatology Conference
6M ago
NOX
Noxopharm Advances SOF-SKN™ to First Human Trials in Australia
PremiumCompany Announcements
Noxopharm Advances SOF-SKN™ to First Human Trials in Australia
6M ago
NOX
Noxopharm Advances Drug Development with Key Agreements and Preclinical Success
PremiumCompany AnnouncementsNoxopharm Advances Drug Development with Key Agreements and Preclinical Success
6M ago
NOX
Noxopharm’s Lupus Drug Clears Final Preclinical Hurdle
Premium
Company Announcements
Noxopharm’s Lupus Drug Clears Final Preclinical Hurdle
6M ago
NOX
Noxopharm Expands Strategic Collaboration to Advance Sofra™ Platform
Premium
Company Announcements
Noxopharm Expands Strategic Collaboration to Advance Sofra™ Platform
7M ago
NOX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >